Edgemoor Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $672K | Sell |
1,910
-1
| -0.1% | -$356 | 0.05% | 109 |
|
|
2025
Q4 | $625K | Sell |
1,911
-178
| -9% | -$56.5K | 0.05% | 111 |
|
|
2025
Q3 | $590K | Buy |
2,089
+186
| +10% | +$53.9K | 0.05% | 123 |
|
|
2025
Q2 | $531K | Sell |
1,903
-2
| -0.1% | -$567 | 0.05% | 120 |
|
|
2025
Q1 | $594K | Sell |
1,905
-140
| -7% | -$41.3K | 0.05% | 111 |
|
|
2024
Q4 | $533K | Sell |
2,045
-80
| -4% | -$23.7K | 0.05% | 114 |
|
|
2024
Q3 | $685K | Sell |
2,125
-25
| -1% | -$8.18K | 0.06% | 107 |
|
|
2024
Q2 | $672K | Sell |
2,150
-75
| -3% | -$22K | 0.06% | 98 |
|
|
2024
Q1 | $633K | Sell |
2,225
-70
| -3% | -$20.5K | 0.06% | 103 |
|
|
2023
Q4 | $661K | Hold |
2,295
| – | – | 0.07% | 100 |
|
|
2023
Q3 | $617K | Hold |
2,295
| – | – | 0.07% | 104 |
|
|
2023
Q2 | $510K | Hold |
2,295
| – | – | 0.06% | 111 |
|
|
2023
Q1 | $555K | Buy |
2,295
+4
| +0.2% | +$982 | 0.07% | 104 |
|
|
2022
Q4 | $602K | Buy |
2,291
+179
| +8% | +$48K | 0.08% | 107 |
|
|
2022
Q3 | $476K | Hold |
2,112
| – | – | 0.06% | 106 |
|
|
2022
Q2 | $514K | Buy |
2,112
+197
| +10% | +$48.3K | 0.06% | 108 |
|
|
2022
Q1 | $463K | Buy |
1,915
+265
| +16% | +$60.9K | 0.05% | 114 |
|
|
2021
Q4 | $371K | Buy |
1,650
+294
| +22% | +$62.1K | 0.04% | 112 |
|
|
2021
Q3 | $288K | Sell |
1,356
-11
| -0.8% | -$2.53K | 0.03% | 111 |
|
|
2021
Q2 | $333K | Sell |
1,367
-3
| -0.2% | -$738 | 0.03% | 107 |
|
|
2021
Q1 | $341K | Buy |
1,370
+9
| +0.7% | +$2.15K | 0.03% | 100 |
|
|
2020
Q4 | $313K | Hold |
1,361
| – | – | 0.04% | 101 |
|
|
2020
Q3 | $346K | Hold |
1,361
| – | – | 0.04% | 97 |
|
|
2020
Q2 | $321K | Hold |
1,361
| – | – | 0.04% | 97 |
|
|
2020
Q1 | $276K | Buy |
1,361
+11
| +0.8% | +$2.4K | 0.05% | 99 |
|
|
2019
Q4 | $325K | Hold |
1,350
| – | – | 0.04% | 108 |
|
|
2019
Q3 | $261K | Hold |
1,350
| – | – | 0.03% | 117 |
|
|
2019
Q2 | $249K | Hold |
1,350
| – | – | 0.03% | 123 |
|
|
2019
Q1 | $256K | Hold |
1,350
| – | – | 0.03% | 123 |
|
|
2018
Q4 | $263K | Sell |
1,350
-250
| -16% | -$48.8K | 0.04% | 114 |
|
|
2018
Q3 | $332K | Hold |
1,600
| – | – | 0.04% | 107 |
|
|
2018
Q2 | $295K | Sell |
1,600
-103
| -6% | -$18.2K | 0.04% | 112 |
|
|
2018
Q1 | $290K | Hold |
1,703
| – | – | 0.04% | 116 |
|
|
2017
Q4 | $316K | Buy |
+1,703
| New | +$301K | 0.04% | 114 |
|
Other funds holding AMGN
VCM
VPM
Edgemoor Investment Advisors's AMGN Position: Q1 2026 in Review
Edgemoor Investment Advisors reduced its Amgen (AMGN) stake by 0.05% in Q1 2026, selling an estimated $356 and leaving 1,910 shares worth $672K. The position accounts for 0.05% of the portfolio, ranked #109.
Edgemoor Investment Advisors first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. The position peaked at $685K in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Edgemoor Investment Advisors held 1,910 shares of Amgen worth $672K as of Q1 2026.
- Edgemoor Investment Advisors sold 1 Amgen share in Q1 2026, an estimated $356.
- Amgen made up 0.05% of Edgemoor Investment Advisors's portfolio in Q1 2026, its #109 holding.
- Edgemoor Investment Advisors first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
- Edgemoor Investment Advisors's Amgen position peaked at $685K in Q3 2024.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Edgemoor Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.